Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CYTH | US
-0.01
-1.39%
Healthcare
Biotechnology
30/06/2024
18/10/2024
0.77
0.78
0.79
0.75
Cyclo Therapeutics Inc. a clinical stage biotechnology company develops cyclodextrin-based products for the treatment of neurodegenerative diseases. Its lead drug candidate is Trappsol Cyclo an orphan drug which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo that is in Phase IIb clinical trials for the treatment of Alzheimer's disease. In addition it sells cyclodextrins and related products to the pharmaceutical nutritional and other industries primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings Inc. and changed its name to Cyclo Therapeutics Inc. in September 2019. Cyclo Therapeutics Inc. was incorporated in 1990 and is based in Gainesville Florida.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
39.8%1 month
54.8%3 months
83.6%6 months
76.3%-
-
59.10
-0.59
0.64
-0.47
21.55
-
-21.14M
22.21M
22.21M
-
-4.58K
-
5.10
-22.66K
3.25
0.68
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.14
Range1M
0.17
Range3M
0.75
Rel. volume
0.68
Price X volume
19.55K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
RenovoRx Inc. Common Stock | RNXT | Biotechnology | 1 | 23.99M | 0.00% | n/a | 0.00% |
Bolt Technology Corp | BOLT | Biotechnology | 0.6264 | 23.97M | -1.82% | n/a | 22.00% |
ImmunoCellular Therapeutics Ltd | IMUC | Biotechnology | 0.14 | 23.43M | 1.45% | 0.02 | -82.78% |
Aligos Therapeutics Inc | ALGS | Biotechnology | 7.25 | 23.17M | 0.55% | n/a | 14.63% |
BioXcel Therapeutics Inc | BTAI | Biotechnology | 0.5658 | 23.05M | -0.74% | n/a | -139.46% |
Pieris Pharmaceuticals Inc | PIRS | Biotechnology | 16.919 | 22.07M | -0.06% | n/a | 0.00% |
Spruce Biosciences Inc | SPRB | Biotechnology | 0.519 | 21.44M | 1.76% | n/a | 6.24% |
NeuroSense Therapeutics Ltd. Ordinary Shares | NRSN | Biotechnology | 1.07 | 21.20M | -2.73% | n/a | -2.11% |
Cocrystal Pharma Inc | COCP | Biotechnology | 2.0718 | 21.08M | 1.56% | n/a | 10.24% |
Matinas BioPharma Holdings Inc | MTNB | Biotechnology | 4.12 | 20.86M | 0.98% | n/a | 16.97% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.9 | 19.65M | 2.38% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 1.03 | 18.60M | 5.10% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.538 | 7.80M | -6.65% | 0.03 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2201 | 3.95M | 4.26% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.06 | 2.76M | 1.92% | n/a | 17.32% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.01 | 897.66K | -12.28% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.38 | 0 | 0.37% | 22.53 | 56.33% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 3.92 | 0 | -8.84% | n/a | 0.00% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.4801 | 0 | -10.26% | n/a | 19.98% |
Urban One Inc | UONEK | Broadcasting - Radio | 1.045 | 0 | -2.34% | n/a | 268.43% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.47 | 0.53 | Cheaper |
Ent. to Revenue | 21.55 | 3,967.00 | Cheaper |
PE Ratio | - | 41.03 | - |
Price to Book | 59.10 | 15.55 | Expensive |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 83.60 | 72.80 | Par |
Debt to Equity | -0.59 | -1.23 | Expensive |
Debt to Assets | 0.64 | 0.25 | Expensive |
Market Cap | 22.21M | 3.66B | Emerging |